HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ainara Magdaleno Selected Research

WAY-262611

11/2021Dickkopf-1 Inhibition Reactivates Wnt/β-Catenin Signaling in Rhabdomyosarcoma, Induces Myogenic Markers In Vitro and Impairs Tumor Cell Survival In Vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ainara Magdaleno Research Topics

Disease

3Neoplasms (Cancer)
11/2021 - 08/2021
1Rhabdomyosarcoma
11/2021
1Sarcoma (Soft Tissue Sarcoma)
11/2021
1Neuroblastoma
09/2021

Drug/Important Bio-Agent (IBA)

1CateninsIBA
11/2021
1Pharmaceutical PreparationsIBA
11/2021
1WAY-262611IBA
11/2021
1Messenger RNA (mRNA)IBA
09/2021
1Proteins (Proteins, Gene)FDA Link
08/2021

Therapy/Procedure

2Therapeutics
09/2021 - 08/2021